A general view of CD33+ leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy
figure
Characteristics of DNMT3A mutations in acute myeloid leukemia
figure
Clinical significance of myeloproliferative neoplasms with JAK2V617F mutations and major BCR-ABL1 translocations: a literature review with case presentation
figure
Blood Res 2020; 55(1): 1~69
Review Articles
Bibliometric analysis of studies about acute myeloid leukemia conducted globally from 1999 to 2018
Beomjun Seo, Jeeyoon Kim, Seungwook Kim et al.
Blood Res 2020; 55(1): 1-9  https://doi.org/10.5045/br.2020.55.1.1 PDF PubMed Central
A general view of CD33+ leukemic stem cells and CAR-T cells as interesting targets in acute myeloblatsic leukemia therapy
Ezzatollah Fathi, Raheleh Farahzadi, Roghayeh Sheervalilou et al.
Blood Res 2020; 55(1): 10-16  https://doi.org/10.5045/br.2020.55.1.10 PDF PubMed Central
Original Articles
Characteristics of DNMT3A mutations in acute myeloid leukemia
Dong Jin Park, Ahlm Kwon, Byung-Sik Cho et al.
Blood Res 2020; 55(1): 17-26  https://doi.org/10.5045/br.2020.55.1.17 PDF PubMed Central
Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
Mihong Choi, Ja Yoon Heo, Dong-Yeop Shin et al.
Blood Res 2020; 55(1): 27-34  https://doi.org/10.5045/br.2020.55.1.27 PDF PubMed Central
Human platelet lysate efficiency, stability, and optimal heparin concentration required in culture of mammalian cells
Hoda E. Mohamed, Mervat E. Asker, Nahla S. Kotb et al.
Blood Res 2020; 55(1): 35-43  https://doi.org/10.5045/br.2020.55.1.35 PDF PubMed Central
Thromboprophylaxis after bariatric surgery
Feras M. Almarshad, Mosaad Almegren, Turki Alshuaibi et al.
Blood Res 2020; 55(1): 44-48  https://doi.org/10.5045/br.2020.55.1.44 PDF PubMed Central
HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases
Ya-Jun Li, Ji-Wei Li, Kai-Lin Chen et al.
Blood Res 2020; 55(1): 49-56  https://doi.org/10.5045/br.2020.55.1.49 PDF PubMed Central
Original Articles
Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
Aaron Wu, Solomon A. Graf, Nicholas Burwick et al.
Blood Res 2020; 55(1): 57-61  https://doi.org/10.5045/br.2020.55.1.57 PDF PubMed Central
Letters to the Editor
Clinical significance of myeloproliferative neoplasms with JAK2V617F mutations and major BCR-ABL1 translocations: a literature review with case presentation
Bohyun Kim, Kyu Taek Lee, Young Ahn Yoon et al.
Blood Res 2020; 55(1): 62-65  https://doi.org/10.5045/br.2020.55.1.62 PDF PubMed Central
Daratumumab in dialysis-dependent multiple myeloma
Preethi Jeyaraman, Alka Bhasin, Nitin Dayal et al.
Blood Res 2020; 55(1): 65-67  https://doi.org/10.5045/br.2020.55.1.65 PDF PubMed Central
Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
Stephen E. Langabeer
Blood Res 2020; 55(1): 67-68  https://doi.org/10.5045/br.2020.55.1.67 PDF PubMed Central
Response to the letter by Langabeer on ?Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria‰
Ik-Chan Song
Blood Res 2020; 55(1): 68-68  https://doi.org/10.5045/br.2020.55.1.68 PDF PubMed Central
Helicobacter pylori testing in a population of Korean patients with pernicious anemia
Ik-Chan Song, Myung-Won Lee, Seung-Woo Baek et al.
Blood Res 2020; 55(1): 69-69  https://doi.org/10.5045/br.2020.55.1.69 PDF PubMed Central

Current Issue

31 March 2020 Volume 55.
Number 1 pp. 1~69
ba_link01
Today : 44  /
Total : 202,411